These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2072578)
1. [Immunohistochemical alterations in basement membrane components in skin cancer]. Oguro K Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):105-13. PubMed ID: 2072578 [TBL] [Abstract][Full Text] [Related]
2. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin. Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical alterations in basement membrane components of squamous cell carcinoma. Oguro K; Kazama T; Isemura M; Nakamura T; Akai S; Sato Y J Invest Dermatol; 1991 Feb; 96(2):250-4. PubMed ID: 1991985 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin. Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma. Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611 [TBL] [Abstract][Full Text] [Related]
6. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases. Liu H; Takeuchi S; Moroi Y; Lin N; Urabe K; Kokuba H; Imafuku S; Dainichi T; Uchi H; Furue M; Tu Y Int J Dermatol; 2007 Nov; 46(11):1171-6. PubMed ID: 17988337 [TBL] [Abstract][Full Text] [Related]
7. Altered expression of NU-T2-BMZ antigen and type VII collagen in basal cell epithelioma. Yasaka N; Kawabe K; Furue M; Tamaki K; Ishibashi Y J Dermatol Sci; 1994 Apr; 7(2):136-41. PubMed ID: 8060915 [TBL] [Abstract][Full Text] [Related]
8. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma]. Mihailovici MS; Teleman S; Ungureanu C Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors. Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663 [TBL] [Abstract][Full Text] [Related]
10. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Hida Y; Kubo Y; Murao K; Arase S Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656 [TBL] [Abstract][Full Text] [Related]
11. Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx. Nerlich AG; Lebeau A; Hagedorn HG; Sauer U; Schleicher ED Anticancer Res; 1998; 18(5A):3515-20. PubMed ID: 9858933 [TBL] [Abstract][Full Text] [Related]
12. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas. Wrone DA; Yoo S; Chipps LK; Moy RL Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526 [TBL] [Abstract][Full Text] [Related]
13. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma. Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674 [TBL] [Abstract][Full Text] [Related]
14. [Nuclear DNA content in the cells of squamous cell carcinoma and Bowen's disease. II. A study on DNA contents of deeply invaded cells in comparison with non-invading cells at the upper dermis]. Toyoshima H Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):835-8. PubMed ID: 2232291 [TBL] [Abstract][Full Text] [Related]
15. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease. Bagazgoitia L; Cuevas J; Juarranz A J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):228-30. PubMed ID: 19515076 [TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical analysis of the basement membrane expression in squamous epithelial carcinoma of the larynx]. Hagedorn H; Schreiner M; Wiest I; Nerlich A Laryngorhinootologie; 1994 Dec; 73(12):637-41. PubMed ID: 7840826 [TBL] [Abstract][Full Text] [Related]
17. Collagen IV, laminin, fibronectin, vitronectin. Comparative study in basal cell carcinoma. Correlation between basement membrane molecules expression and invasive potential. Marasà L; Marasà S; Sciancalepore G G Ital Dermatol Venereol; 2008 Jun; 143(3):169-73. PubMed ID: 18833058 [TBL] [Abstract][Full Text] [Related]
18. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma]. Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929 [TBL] [Abstract][Full Text] [Related]
19. Prognostic aspects of the loss of epithelial basement membrane components in preinvasive and invasive laryngeal carcinomas. Hagedorn HG; Tübel J; Wiest I; Schleicher ED; Nerlich AG Anticancer Res; 1998; 18(1A):201-7. PubMed ID: 9568078 [TBL] [Abstract][Full Text] [Related]
20. Basal membrane heparan sulphate proteoglycan expression during wound healing in human skin. Andriessen MP; van den Born J; Latijnhouwers MA; Bergers M; van de Kerkhof PC; Schalkwijk J J Pathol; 1997 Nov; 183(3):264-71. PubMed ID: 9422980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]